Preliminary Market Engagement Notice: Targeted Prostate Cancer Screening Programme - PSA Testing, MRI Reporting and BRCA Digital Decision Resource

NHS ENGLAND

This public procurement record has 1 release in its history.

Planning

05 Aug 2026 at 14:30

Summary of the contracting process

NHS England is initiating a preliminary market engagement process for a targeted prostate cancer screening programme, which focuses on PSA testing, MRI reporting, and the development of a BRCA digital decision resource. This effort, classified under the health services sector, is currently in the planning stage and aims to gather insights for three related workstreams. The project involves diverse capabilities and supplier markets within the UK. Suppliers are welcome to express interest in one or more workstreams, which may later be procured separately. Details about the varying procurement methods for each stream are being assessed with anticipated procurement under established regimes, subject to approval. Communication during this planning stage includes future notifications expected on 7th December 2026.

This market engagement offers a significant opportunity for businesses involved in medical laboratory services, medical imaging, and digital platform development to showcase their capabilities and contribute to a vital health initiative. Companies with expertise in these areas, particularly those familiar with NHS pathways and digital resource creation, will find this engagement beneficial for future procurement opportunities. Engaging in this process allows businesses to align with NHS England's objectives and better understand the evolving landscape within the targeted healthcare services market.

How relevant is this notice?

Notice Title

Preliminary Market Engagement Notice: Targeted Prostate Cancer Screening Programme - PSA Testing, MRI Reporting and BRCA Digital Decision Resource

Notice Description

NHS England is undertaking early market engagement to inform three separate requirements within the Targeted Prostate Cancer Screening Programme.

Lot Information

Lot 1

Preliminary Market Engagement / Early Market Engagement

NHS England is undertaking preliminary market engagement to inform three separate but connected requirements within the Targeted Prostate Cancer Screening Programme.

The proposed workstreams are:

1. PSA laboratory processing and pathway support;
2. prostate MRI reporting;
3. BRCA digital decision resource / website development and evaluation.

The programme is being developed to support targeted prostate cancer screening for men at increased risk, including men with a known pathogenic or likely pathogenic BRCA2 variant. The purpose of this engagement is to understand market capability, potential delivery models, mobilisation requirements, key risks, pricing assumptions, digital and information governance considerations, pathway interfaces and route-to-market options.

The workstreams involve different capabilities and provider markets. NHS England may procure the requirements separately, and different procurement routes may apply to different workstreams. NHS England is currently assessing the most appropriate route to market for each workstream. Subject to completion of the relevant approvals and assessments, Workstreams 1 and 2 are anticipated to be procured under the Provider Selection Regime where confirmed as being within scope of that regime. Workstream 3 is anticipated to be procured in accordance with the Procurement Act 2023.

This engagement is not a call for competition, does not commence a procurement process, and does not commit NHS England to any procurement, route to market, contract award or level of expenditure. Participation in this engagement is not required in order to participate in any future procurement process, and non-participation will not prevent participation in any future opportunity.

Suppliers may respond to one, two or all three workstreams, depending on their capability and interest.

The Preliminary Market Engagement Notice uses 85100000-0 Health services as the main CPV code because the engagement relates to a targeted screening programme and includes two clinical/diagnostic workstreams. Additional CPV codes have been included to reflect the specific workstreams: PSA laboratory processing and medical analysis, prostate MRI reporting, and digital decision resource / website development. The use of multiple CPV codes reflects the fact that this is one combined market engagement exercise only; the workstreams may be procured separately and may follow different procurement routes following Commercial review.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06dcb3
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/074308-2026
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
Planning Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services


CPV Codes

85100000 - Health services

85145000 - Services provided by medical laboratories

85148000 - Medical analysis services

85150000 - Medical imaging services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
5 Aug 2026Today
Submission Deadline
Not specified
Future Notice Date
7 Dec 20265 months to go
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Planned
Lots Status
Planned
Awards Status
Not Specified
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
NHS ENGLAND
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE1 8UG
Post Town
South East London
Country
England

Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI45 Lambeth
Delivery Location
Not specified

Local Authority
Lambeth
Electoral Ward
Waterloo & South Bank
Westminster Constituency
Vauxhall and Camberwell Green

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-06dcb3-2026-08-05T15:30:15+01:00",
    "date": "2026-08-05T15:30:15+01:00",
    "ocid": "ocds-h6vhtk-06dcb3",
    "description": "The Preliminary Market Engagement Notice uses 85100000-0 Health services as the main CPV code as the engagement relates to a targeted screening programme and includes two clinical/diagnostic workstreams. Additional CPV codes included to reflect the specific workstreams: PSA laboratory processing & medical analysis, prostate MRI reporting, & digital decision resource/website development. The use of multiple CPV codes reflects the fact that this is one combined market engagement.<br/><br/>Please note the following CPV codes are being utilised as well for the early engagement (but are not PSR related):<br/><br/>World wide web (www) site design services<br/>72413000<br/>Internet and intranet software development services<br/>72212220<br/>IT services: consulting, software development, Internet and support<br/>72000000<br/><br/>A separate, relevant PA23 early engagement notice has been released with all CPV codes as well.",
    "initiationType": "tender",
    "tender": {
        "id": "C463159",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Preliminary Market Engagement Notice: Targeted Prostate Cancer Screening Programme - PSA Testing, MRI Reporting and BRCA Digital Decision Resource",
        "status": "planned",
        "classification": {
            "scheme": "CPV",
            "id": "85145000",
            "description": "Services provided by medical laboratories"
        },
        "mainProcurementCategory": "services",
        "description": "NHS England is undertaking early market engagement to inform three separate requirements within the Targeted Prostate Cancer Screening Programme.",
        "lots": [
            {
                "id": "1",
                "description": "Preliminary Market Engagement / Early Market Engagement<br/><br/>NHS England is undertaking preliminary market engagement to inform three separate but connected requirements within the Targeted Prostate Cancer Screening Programme.<br/><br/>The proposed workstreams are:<br/><br/>1. PSA laboratory processing and pathway support;<br/>2. prostate MRI reporting;<br/>3. BRCA digital decision resource / website development and evaluation.<br/><br/>The programme is being developed to support targeted prostate cancer screening for men at increased risk, including men with a known pathogenic or likely pathogenic BRCA2 variant. The purpose of this engagement is to understand market capability, potential delivery models, mobilisation requirements, key risks, pricing assumptions, digital and information governance considerations, pathway interfaces and route-to-market options.<br/><br/>The workstreams involve different capabilities and provider markets. NHS England may procure the requirements separately, and different procurement routes may apply to different workstreams. NHS England is currently assessing the most appropriate route to market for each workstream. Subject to completion of the relevant approvals and assessments, Workstreams 1 and 2 are anticipated to be procured under the Provider Selection Regime where confirmed as being within scope of that regime. Workstream 3 is anticipated to be procured in accordance with the Procurement Act 2023.<br/><br/>This engagement is not a call for competition, does not commence a procurement process, and does not commit NHS England to any procurement, route to market, contract award or level of expenditure. Participation in this engagement is not required in order to participate in any future procurement process, and non-participation will not prevent participation in any future opportunity.<br/><br/>Suppliers may respond to one, two or all three workstreams, depending on their capability and interest.<br/><br/>The Preliminary Market Engagement Notice uses 85100000-0 Health services as the main CPV code because the engagement relates to a targeted screening programme and includes two clinical/diagnostic workstreams. Additional CPV codes have been included to reflect the specific workstreams: PSA laboratory processing and medical analysis, prostate MRI reporting, and digital decision resource / website development. The use of multiple CPV codes reflects the fact that this is one combined market engagement exercise only; the workstreams may be procured separately and may follow different procurement routes following Commercial review.",
                "status": "planned"
            }
        ],
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "85100000",
                        "description": "Health services"
                    },
                    {
                        "scheme": "CPV",
                        "id": "85150000",
                        "description": "Medical imaging services"
                    },
                    {
                        "scheme": "CPV",
                        "id": "85148000",
                        "description": "Medical analysis services"
                    },
                    {
                        "scheme": "CPV",
                        "id": "85145000",
                        "description": "Services provided by medical laboratories"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "communication": {
            "futureNoticeDate": "2026-12-07T00:00:00Z",
            "atypicalToolUrl": "https://atamis-1928.my.site.com/s/Welcome"
        },
        "coveredBy": [
            "GPA"
        ]
    },
    "parties": [
        {
            "id": "GB-FTS-130973",
            "name": "NHS England",
            "identifier": {
                "legalName": "NHS England"
            },
            "address": {
                "streetAddress": "Wellington House, 133-135 Waterloo Rd",
                "locality": "London",
                "region": "UKI",
                "postalCode": "SE1 8UG",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "NHS England",
                "email": "england.commercialqueries@nhs.net"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.england.nhs.uk/",
                "buyerProfile": "https://www.england.nhs.uk/",
                "classifications": [
                    {
                        "id": "BODY_PUBLIC",
                        "scheme": "TED_CA_TYPE",
                        "description": "Body governed by public law"
                    },
                    {
                        "id": "07",
                        "scheme": "COFOG",
                        "description": "Health"
                    }
                ]
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-130973",
        "name": "NHS England"
    },
    "language": "en"
}